Fact CheckerSign in

NCT05693909RecruitingPhase 2

A Trial Testing SP-420 in Subjects With Transfusion-dependent β-thalassemia or Low-risk Myelodysplastic Syndromes

An Open-label, Dose-escalation, Dose-finding, and Proof-of-concept Trial of SP-420 in Subjects With Transfusion-dependent β-thalassemia or Low-risk Myelodysplastic Syndromes

Source: ClinicalTrials.gov · Last updated 24 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The goal of this clinical trial is to learn about SP-420 ability to remove iron from organs in subjects with transfusion-dependent β-thalassemia or transfusion-dependent low-risk myelodysplastic syndrome. The main questions it aims to answer are: * How efficient is SP-420 in cleaning iron from the liver? * How is the safety and tolerability of ascending doses of SP-420? Participants will: * Take medication three times weekly * Attend up to 20 site visits * Undergo MRI scans

Status (registry)
Recruiting
Phase (registry)
Phase 2
Study type
Interventional
Enrollment
90 (estimated)
First submitted
22 Dec 2022
Start date
4 Sept 2023
Primary completion date
Oct 2027
Lead sponsor
Pharmacosmos A/S
NCT number
NCT05693909
EU CT number
2023-507396-21-00
EudraCT number
2022-002395-36

What you commit to

  • Study type: Interventional · Phase 2
  • Planned participants: 90
  • From 4 Sept 2023 to the primary completion date, Oct 2027
  • 28 sites in 4 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Therapy-related MDS or MDS with a known bone marrow fibrosis
  • Major surgery within 8 weeks prior to screening

Other illness

  • Current biliary disorder
  • Historic or ongoing clinically significant kidney disease
  • Men who do not agree to practice effective barrier contraception during the entire period
    • Myelodysplastic Syndromes Cohorts:
  • Clinically significant kidney disease, either historic or ongoing
  • Uncontrolled ischemic heart disease or uncontrolled arrythmia
  • Uncontrolled hypertension
  • Uncontrolled Diabetes

Other

  • β-thalassemia with the structural Hb variants HbS and HbC
  • Current MDS
  • Unable to undergo trial assessments including MRI e.g. due to claustrophobia in MRI scanner
  • Pregnant or nursing women
  • Diagnosis of decompensated liver cirrhosis
  • Uncontrolled dyslipidaemia
  • Pregnant or nursing women
  • Men who do not agree to practice effective barrier contraception during the entire period

Who the study is looking for

  • Women and men aged 18 years or older
  • Transfusion-dependent β-thalassemia including HbE/β-thalassemia requiring iron chelation therapy (β-thalassemia with mutation and/or multiplication of α-globin is allowed)
  • On a stable dose of iron chelation for at least 4 weeks prior to screening
  • Weight ≥ 35kg at screening
  • Transfusion iron overload
  • Treated and followed for at least the past 6 months in a specialized centre
  • Women and men aged 18 years or older
  • Very low, low, or intermediate risk Myelodysplastic Syndrome according to IPSS-R
  • Weight ≥ 35kg at screening
  • Transfusion iron overload
  • Treated and followed for at least the past 6 months at medical facilities experienced with MDS

Criteria the registry did not label

  • Thalassemia cohorts:

Age in the registry: 18 years to 64 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (28)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Region Midtjylland
Coordinator of this site? Confirm its status
Aarhus NDenmarkRecruiting
Rigshospitalet
Coordinator of this site? Confirm its status
Copenhagen OeDenmarkRecruiting
Odense University Hospital
Coordinator of this site? Confirm its status
Odense CDenmarkRecruiting
Hippokration Hospital
Coordinator of this site? Confirm its status
AthensGreeceRecruiting
Laiko General Hospital of Athens
Coordinator of this site? Confirm its status
AthensGreeceRecruiting
Nosokomeio Paidon I Agia Sofia
Coordinator of this site? Confirm its status
AthensGreeceRecruiting
University General Hospital "ATTIKON" - General Hospital of West Attica "H AGIA VARVARA"
Coordinator of this site? Confirm its status
ChaïdáriGreeceRecruiting
University General Hospital of Ioannina
Coordinator of this site? Confirm its status
IoanninaGreeceRecruiting
General Hospital Of Larissa Koutlibaneio And Triantafylleio
Coordinator of this site? Confirm its status
LarissaGreeceRecruiting
Olympion Therapeftirio General Clinic Of Patras S.A.
Coordinator of this site? Confirm its status
PatraGreeceRecruiting
Ippokratio General Hospital of Thessaloniki
Coordinator of this site? Confirm its status
ThessalonikiGreeceRecruiting
Geniko Nosokomeio Thessalonikis George Papanikolaou
Coordinator of this site? Confirm its status
ThessalonikiGreeceRecruiting
Azienda Ospedaliero-Universitaria Di Bologna IRCCS Istituto Di Ricerca E Di Cura A Carattere Scientifico
Coordinator of this site? Confirm its status
BolognaItalyRecruiting
ARNAS G. Brotzu
Coordinator of this site? Confirm its status
CagliariItalyRecruiting
Azienda Ospedaliero-Universitaria Careggi
Coordinator of this site? Confirm its status
FlorenceItalyRecruiting
IRCCS Ospedale Policlinico San Martino
Coordinator of this site? Confirm its status
GenoaItalyRecruiting
Ente Ospedaliero Ospedali Galliera Di Genova
Coordinator of this site? Confirm its status
GenoaItalyRecruiting
Ospedale San Raffaele S.r.l.
Coordinator of this site? Confirm its status
MilanItalyRecruiting
ASST Grande Ospedale Metropolitano Niguarda
Coordinator of this site? Confirm its status
MilanItalyRecruiting
Azienda Ospedaliero - Universitaria di Modena
Coordinator of this site? Confirm its status
ModenaItalyRecruiting
Azienda Ospedaliera Universitaria - Universita degli Studi della Campania Luigi Vanvitelli
Coordinator of this site? Confirm its status
NaplesItalyRecruiting
Fondazione IRCCS Policlinico San Matteo
Coordinator of this site? Confirm its status
PaviaItalyRecruiting
Copernicus Podmiot Leczniczy Sp. z o.o
Coordinator of this site? Confirm its status
GdanskPolandRecruiting
Szpital Kliniczny Ministerstwa Spraw Wewnętrznych i Administracji z Warmińsko - Mazurskim Centrum Onkologii w Olsztynie
Coordinator of this site? Confirm its status
OlsztynPolandRecruiting
Szpital Wojewodzki W Opolu Sp. z o.o.
Coordinator of this site? Confirm its status
OpolePolandRecruiting
Aidport sp z o.o.
Coordinator of this site? Confirm its status
SkorzewoPolandRecruiting
Specjalistyczny Szpital Im. Dra Alfreda Sokolowskiego
Coordinator of this site? Confirm its status
WalbrzychPolandRecruiting
MTZ Clinical Research powered by Pratia
Coordinator of this site? Confirm its status
WarsawPolandRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.